# National Institutes of Health's Biotech Investments: 145 Startups in Its Portfolio (2026)

> The 145 Biotech startups National Institutes of Health has backed, by stage: $2.5B raised between them. From the rounds we track; updated nightly.

Source: https://millionrounds.com/portfolio-maps/national-institutes-of-health-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article)

## Stage not reported

113

- [Global Registry of Biorepositories](https://millionrounds.com/company/global-registry-of-biorepositories)
- [*N* NERI](https://millionrounds.com/company/neri)
- [LUCID DIAGNOSTICS INC.](https://millionrounds.com/company/lucid-diagnostics-inc)
- [Akonni Biosystems](https://millionrounds.com/company/akonni-biosystems)
- [Sparian Biosciences](https://millionrounds.com/company/sparian-biosciences)
- [Trefoil Therapeutics](https://millionrounds.com/company/trefoil-therapeutics)
- [Clene Nanomedicine](https://millionrounds.com/company/clene-nanomedicine)
- [MAIA Biotechnology](https://millionrounds.com/company/maia-biotechnology)
- [CODA Biotherapeutics](https://millionrounds.com/company/coda-biotherapeutics)
- [Transcode Therapeutics](https://millionrounds.com/company/transcode-therapeutics)
- [Magnetic Insight](https://millionrounds.com/company/magnetic-insight)
- [RevBio](https://millionrounds.com/company/revbio)
- [Thetis Pharmaceuticals](https://millionrounds.com/company/thetis-pharmaceuticals)
- [*VT* Vast Therapeutics](https://millionrounds.com/company/vast-therapeutics)
- [*G* Galenea](https://millionrounds.com/company/galenea)
- [Spinogenix](https://millionrounds.com/company/spinogenix)
- [POP Biotechnologies](https://millionrounds.com/company/pop-biotechnologies)
- [Micro-Leads](https://millionrounds.com/company/micro-leads)
- [Immunetics](https://millionrounds.com/company/immunetics)
- [Mustang Bio](https://millionrounds.com/company/mustang-bio)
- [CoapTech](https://millionrounds.com/company/coaptech)
- [Oligomerix](https://millionrounds.com/company/oligomerix)
- [Myosin Therapeutics](https://millionrounds.com/company/myosin-therapeutics)
- [Anavasi Diagnostics](https://millionrounds.com/company/anavasi-diagnostics)

+89 more

## Series B

10

- [Noom](https://millionrounds.com/company/noom)
- [Windgap Medical](https://millionrounds.com/company/windgap-medical)
- [Allyx Therapeutics](https://millionrounds.com/company/allyx-therapeutics)
- [Nanopath](https://millionrounds.com/company/nanopath)
- [Kinoxis Therapeutics](https://millionrounds.com/company/kinoxis-therapeutics)
- [iotaMotion](https://millionrounds.com/company/iotamotion)
- [SonoMotion](https://millionrounds.com/company/sonomotion)
- [Cell Microsystems](https://millionrounds.com/company/cell-microsystems)
- [Astrocyte Pharmaceuticals](https://millionrounds.com/company/astrocyte-pharmaceuticals)
- [Immunicom](https://millionrounds.com/company/immunicom)

## Series A

8

- [ProLynx](https://millionrounds.com/company/prolynx)
- [Azitra](https://millionrounds.com/company/azitra)
- [Artio Medical](https://millionrounds.com/company/artio-medical)
- [Fesarius Therapeutics](https://millionrounds.com/company/fesarius-therapeutics)
- [SEngine Precision Medicine](https://millionrounds.com/company/sengine-precision-medicine)
- [Novosteo](https://millionrounds.com/company/novosteo)
- [*CS* Cordex Systems](https://millionrounds.com/company/cordex-systems)
- [Trace Biosciences](https://millionrounds.com/company/trace-biosciences)

## Pre-seed and seed

8

- [Fauna Bio](https://millionrounds.com/company/fauna-bio)
- [Psilera](https://millionrounds.com/company/psilera)
- [Immuto Scientific](https://millionrounds.com/company/immuto-scientific)
- [Partillion Bioscience](https://millionrounds.com/company/partillion-bioscience)
- [*AT* Advent Therapeutics](https://millionrounds.com/company/advent-therapeutics)
- [dfusion](https://millionrounds.com/company/dfusion)
- [Sedia Biosciences](https://millionrounds.com/company/sedia-biosciences)
- [O2 RegenTech](https://millionrounds.com/company/o2-regentech)

## Series C and later

6

- [23andMe](https://millionrounds.com/company/23andme)
- [Recursion Pharmaceuticals](https://millionrounds.com/company/recursion-pharmaceuticals)
- [ONL Therapeutics](https://millionrounds.com/company/onl-therapeutics)
- [SeLux Diagnostics](https://millionrounds.com/company/selux-diagnostics)
- [Symic Bio](https://millionrounds.com/company/symic-bio)
- [Airway Therapeutics](https://millionrounds.com/company/airway-therapeutics)

## Segment by segment

### Stage not reported

113 startups · $702M raised

- [**Global Registry of Biorepositories**](https://millionrounds.com/company/global-registry-of-biorepositories) The Global Registry of Biorepositories is a clearing house of information on biological collections in biorepositories. Denmark $45M
- [*N* **NERI**](https://millionrounds.com/company/neri) NERI is a research organization delivering customized research and clinical trial solutions to private public-sector organizations. United States $45M
- [**LUCID DIAGNOSTICS INC.**](https://millionrounds.com/company/lucid-diagnostics-inc) Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer. United States $45M
- [**Akonni Biosystems**](https://millionrounds.com/company/akonni-biosystems) Akonni Biosystems is a biotechnology company that develops and manufactures, genetic testing devices. United States $45M
- [**Sparian Biosciences**](https://millionrounds.com/company/sparian-biosciences) Sparian Biosciences is a biopharmaceutical company. United States $35M
- [**Trefoil Therapeutics**](https://millionrounds.com/company/trefoil-therapeutics) Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases. United States $33M
- [**Clene Nanomedicine**](https://millionrounds.com/company/clene-nanomedicine) Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases. United States $32M
- [**MAIA Biotechnology**](https://millionrounds.com/company/maia-biotechnology) MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy. United States $30M

### Series B

10 startups · $298M raised

- [**Noom**](https://millionrounds.com/company/noom) Noom is a prominent digital health company based in New York City, founded in 2008 by Saeju Jeong and Artem Petakov. United States $86M
- [**Windgap Medical**](https://millionrounds.com/company/windgap-medical) WindGap Medical is a biotech company that manufactures medical devices used to treat patients with severe allergies. United States $70M
- [**Allyx Therapeutics**](https://millionrounds.com/company/allyx-therapeutics) Allyx Therapeutics is a clinical-stage biotechnology company based in New Haven, Connecticut, founded in 2019. United States $61M
- [**Nanopath**](https://millionrounds.com/company/nanopath) Nanopath Inc. United States $25M
- [**Kinoxis Therapeutics**](https://millionrounds.com/company/kinoxis-therapeutics) Kinoxis Therapeutics is a biotechnology company that develops a range of novel therapeutic compounds. Australia $14M
- [**iotaMotion**](https://millionrounds.com/company/iotamotion) IotaMotion is a medical technology company developing robotics-assisted solutions for cochlear implant surgery. United States $13M
- [**SonoMotion**](https://millionrounds.com/company/sonomotion) Sonomotion is a medical device manufacturing company that specializes in providing medical solutions for kidney stones disease. United States $12M
- [**Cell Microsystems**](https://millionrounds.com/company/cell-microsystems) Cell Microsystems is a biotechnology company based in Durham, North Carolina, founded in 2010. United States $6.5M

### Series A

8 startups · $189M raised

- [**ProLynx**](https://millionrounds.com/company/prolynx) Prolynx is a clinical-stage biotechnology company based in the San Francisco Bay Area, founded in 2009. United States $70M
- [**Azitra**](https://millionrounds.com/company/azitra) Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases. United States $49M
- [**Artio Medical**](https://millionrounds.com/company/artio-medical) Artio Medical develops endovascular medical devices for the embolization of vessels, aneurysms, and other vascular structures. United States $28M
- [**Fesarius Therapeutics**](https://millionrounds.com/company/fesarius-therapeutics) Fesarius Therapeutics is a bioregenerative medical technology company based in New York, founded in 2015 by Dr. United States $21M
- [**SEngine Precision Medicine**](https://millionrounds.com/company/sengine-precision-medicine) SEngine Precision Medicine uses algorithms and 3D organoid technology to develop drugs with more efficacy. United States $10M
- [**Novosteo**](https://millionrounds.com/company/novosteo) Novosteo, test the efficacy of a new drug to help reduce complications from a broken bone due to a fall. - $5.5M
- [*CS* **Cordex Systems**](https://millionrounds.com/company/cordex-systems) United States $5.0M
- [**Trace Biosciences**](https://millionrounds.com/company/trace-biosciences) Trace Biosciences is a biotechnology startup founded in 2019, focused on developing targeted imaging agents that enhance nerve vis United States $300K

### Pre-seed and seed

8 startups · $47M raised

- [**Fauna Bio**](https://millionrounds.com/company/fauna-bio) Fauna Bio is an AI-driven biotechnology company founded in 2018, based in Emeryville, California, with an additional office in Berkeley. United States $13M
- [**Psilera**](https://millionrounds.com/company/psilera) Psilera is a biopharmaceutical company founded in 2019, focused on developing innovative neuroplastogens, non-hallucinogenic compou United States $11M
- [**Immuto Scientific**](https://millionrounds.com/company/immuto-scientific) Immuto Scientific is a biotechnology company founded in 2018, with locations in Madison, Wisconsin, and Cambridge, Massachusetts. United States $8.0M
- [**Partillion Bioscience**](https://millionrounds.com/company/partillion-bioscience) Partillion Bioscience is an early-stage life science company developing a functional single-cell analysis platform. United States $7.1M
- [*AT* **Advent Therapeutics**](https://millionrounds.com/company/advent-therapeutics) Advent Therapeutics is focused on providing therapies for micro-orphan applications. United States $3.0M
- [**dfusion**](https://millionrounds.com/company/dfusion) dfusion, a team of scientists and innovators, develops technology to promote evidence-based, health-related behavioral changes. United States $2.8M
- [**Sedia Biosciences**](https://millionrounds.com/company/sedia-biosciences) Sedia Biosciences develops and sells medical diagnostic tests and monitoring tools used to battle against pandemics. United States $1.5M
- [**O2 RegenTech**](https://millionrounds.com/company/o2-regentech) Our novel platform biopolymer technology, OXAIDTM, will be the first on the market to combine the benefits of providing oxygen wit United States $250K

### Series C and later

6 startups · $1.3B raised

- [**23andMe**](https://millionrounds.com/company/23andme) United States $729M
- [**Recursion Pharmaceuticals**](https://millionrounds.com/company/recursion-pharmaceuticals) Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning. United States $339M
- [**ONL Therapeutics**](https://millionrounds.com/company/onl-therapeutics) ONL Therapeutics is a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, founded in 2011. United States $67M
- [**SeLux Diagnostics**](https://millionrounds.com/company/selux-diagnostics) SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients. United States $48M
- [**Symic Bio**](https://millionrounds.com/company/symic-bio) Symic Bio is a biopharmaceutical company based in San Francisco, California, founded in 2012. United States $41M
- [**Airway Therapeutics**](https://millionrounds.com/company/airway-therapeutics) Airway Therapeutics is a clinical-stage biopharmaceutical company based in Cincinnati, Ohio, founded in 2011 as a spin-out from Ci United States $29M

**How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names National Institutes of Health as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

## More portfolio maps

[All portfolios](https://millionrounds.com/portfolio-maps)

[Sector portfolio **National Institutes of Health's Healthtech portfolio** 46 startups · $487M](https://millionrounds.com/portfolio-maps/national-institutes-of-health-healthtech-portfolio)[Sector portfolio **National Institutes of Health's AI portfolio** 15 startups · $107M](https://millionrounds.com/portfolio-maps/national-institutes-of-health-ai-portfolio)[Portfolio map **National Institutes of Health portfolio map** 232 startups · $3.3B](https://millionrounds.com/portfolio-maps/national-institutes-of-health-portfolio-map)[Co-investors **Who invests with National Institutes of Health** 42 co-investors](https://millionrounds.com/portfolio-maps/national-institutes-of-health-co-investors)[Sector portfolio **National Science Foundation's Biotech portfolio** 250 startups · $2.0B](https://millionrounds.com/portfolio-maps/nsf-small-business-innovation-research-small-business-techno-biotech-portfolio)[Sector portfolio **National Science Foundation's Healthtech portfolio** 149 startups · $516M](https://millionrounds.com/portfolio-maps/nsf-small-business-innovation-research-small-business-techno-healthtech-portfolio)

## Raising from investors like National Institutes of Health?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

[Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)